Stop Treatment in gout
Key facts
- Phase
- Phase 2
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorTrial details
- Who runs it
- Assistance Publique Hopitaux De Paris
- Trial code
- EU 2024-515714-40-00
- Record updated
- 28 August 2026
- Original description
to demonstrate that oral ULT withdrawal in patients with gout in remission, monitored with US scans, is not inferior to maintaining oral ULT for the risk of flares at 2 yearsRead full original descriptionShow less
STING - Maintenance or withdrawal of urate lowering therapy according to ultrasound features in gout patients: a randomised controlled trial
to demonstrate that oral ULT withdrawal in patients with gout in remission, monitored with US scans, is not inferior to maintaining oral ULT for the risk of flares at 2 years
Inclusion: Age ≥ 18 years; Gout, defined according to the 2015 ACR/EULAR classification criteria; No flares for at least 2 years; No tophi; Currently receiving allopurinol or febuxostat taken for at least 2 years and SUA levels ≤ 60 mg/l; No urate deposit on ultrasound (score 0/24) at inclusion visit at both MTPs 1 and knees; Ability to provide informed consent; Health Insurance.
Exclusion: Ongoing treatment with uricosurics (benzbromarone and probenecid) or uricase; Unstable systemic medical condition (e.g., New York Heart Association stage IV heart failure, recent myocardial infarction, advanced cancer); History of allergy to allopurinol or febuxostat or one of the excipients • Association with; CKD stage 4 (eGFR less than 30 ml/mn/1.73 m2); Women of childbearing age; Association with azathioprine, mercaptopurine (cytostatics-antimetabolites); Contraindications to experimental medicinal products or auxiliary medicinal products; Patient on SMA (state medical aid-AME); Participation in other clinical trial on medicinal product for human use.